Clinical Trial Update: STAR Cape+BKM120 MBC With Brain Met [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for STAR Cape+BKM120 in metastatic breast cancer with brain metastases has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• BKM120 (Buparlisib)

Snippet

Sponsor: US Oncology Research | Conditions: Brain Metastases, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-02-01